PainReform Ltd (NASDAQ:PRFX) price on current trading day, fall -25.56% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.35.
A look at the stock’s price movement, the close in the last trading session was $4.50, moving within a range at $3.05 and $3.7299. The beta value (5-Year monthly) was 0.555. Turning to its 52-week performance, $80.64 and $1.73 were the 52-week high and 52-week low respectively. Overall, PRFX moved 49.61% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PainReform Ltd’s market cap currently stands at around $1.98 million, with investors looking forward to this quarter’s earnings report slated for in January.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PRFX is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
PRFX’s current price about 13.38% and 25.94% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.86, while 7-day volatility ratio is 23.75% and 21.44% in the 30-day chart. Further, PainReform Ltd (PRFX) has a beta value of 0.70, and an average true range (ATR) of 0.87.
If we refocus on PainReform Ltd (NASDAQ:PRFX), historical trading data shows that trading volumes averaged 4.52 over the past 10 days and 1.59 million over the past 3 months. The company’s latest data on shares outstanding shows there are 3.47 million shares.
The 5.13% of PainReform Ltd’s shares are in the hands of company insiders while institutional holders own 2.47% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 29100.0 on 2024-11-15, giving us a short ratio of 0.36. The data shows that as of 2024-11-15 short interest in PainReform Ltd (PRFX) stood at 537.0 of shares outstanding, with shares short rising to 15268.0 registered in 2024-10-15. Current price change has pushed the stock -94.92% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PRFX stock continues to rise going into the next quarter.
